A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma
Clinical trial NCT01153763 · COMPLETED
Trial details
- NCT number
- NCT01153763
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-09
- Primary completion
- 2011-07-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.